Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission?

PURPOSE: Patients with acute myeloid leukemia (AML) who are in morphologic complete remission are typically considered separately from patients with active disease (ie, ≥ 5% marrow blasts by morphology) in treatment algorithms for allogeneic hematopoietic cell transplantation (HCT), which implies di...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Araki, Daisuke, Wood, Brent L., Othus, Megan, Radich, Jerald P., Halpern, Anna B., Zhou, Yi, Mielcarek, Marco, Estey, Elihu H., Appelbaum, Frederick R., Walter, Roland B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2016
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872033/
https://ncbi.nlm.nih.gov/pubmed/26668349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.3826
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi